|
|
Volumn 296, Issue 5571, 2002, Pages 1212-1213
|
|
DuPont ups ante on use of Harvard's OncoMouse
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER MODEL;
CANCER RESEARCH;
CANCER SUSCEPTIBILITY;
CLINICAL RESEARCH;
EXPERIMENTAL ANIMAL;
MOUSE;
NONHUMAN;
NOTE;
PATENT;
PRIORITY JOURNAL;
TRANSGENIC MOUSE;
ANIMAL;
ARTICLE;
DISEASE MODEL;
DRUG INDUSTRY;
DRUG SCREENING;
EXPERIMENTAL NEOPLASM;
HEALTH CARE ORGANIZATION;
LEGAL ASPECT;
UNITED STATES;
UNIVERSITY;
ANIMALS;
DISEASE MODELS, ANIMAL;
DRUG INDUSTRY;
DRUG SCREENING ASSAYS, ANTITUMOR;
MICE;
MICE, TRANSGENIC;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASMS, EXPERIMENTAL;
PATENTS;
UNITED STATES;
UNIVERSITIES;
|
|
EID: 0037123668
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.296.5571.1212 Document Type: Note |
|
Times cited : (22)
|
|
References (0)
|